• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON & CO. (SPARKS) BD BBL¿ TRYPTICASE¿ SOY BROTH; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON & CO. (SPARKS) BD BBL¿ TRYPTICASE¿ SOY BROTH; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL Back to Search Results
Catalog Number 221716
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/30/2023
Event Type  malfunction  
Manufacturer Narrative
E.1.Initial reporter facility name: (b)(6).G5: pma/510(k)#: preamendment.H.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that while using bd bbl¿ trypticase¿ soy broth, there was contamination of 5 tubes.No patient impact reported.The following information was provided by the initial reporter: "this is report about trypticase soy broth contamination.There is a discrepancy in the culture results when culturing the catheter tip.".
 
Event Description
It was reported that while using bd bbl¿ trypticase¿ soy broth, there was contamination of 5 tubes.No patient impact reported.The following information was provided by the initial reporter: "this is report about trypticase soy broth contamination.There is a discrepancy in the culture results when culturing the catheter tip.".
 
Manufacturer Narrative
The following fields have been updated with additional information: d10.Device available for eval- yes.D10.Returned to manufacturer on: 18-mar-2024.H.6.Investigation summary: the batch history record review for batch 2272714 was satisfactory per internal procedures.Formulation, filling, torquing, and autoclaving processes were within specifications.In process checks were performed at the designated intervals.Those checks confirmed that the caps were tightened to the validated specifications per internal procedure.Qc inspection and testing were satisfactory at time of release.As part of the release criteria for this product, the bhr was reviewed to confirm the following: the total elapsed time between end of formulation and start of the autoclave cycle was within the specified limits.All autoclave parameters conformed to the validated cycle parameters for this product.The minimum f0 for this product was met.The complaint history was reviewed and there is one other contamination complaint on batch 2271714.Retention samples were not available for inspection.There were three (3) photos received to assist in the investigation of batch 2272714.Two photos show two slightly hazy tubes, one with labeled batch 2272714.The tube caps were wrapped in parafilm.One photo shows the labeled portion of the tubes with batch 2272714 displayed.Two (2) tubes batch 2272714 were returned in a bag with bubble wrap in a box with returns for three (3) other complaints, with the caps wrapped in parafilm.The tubes were trace hazy and incubated at 35 degrees celsius for 21 days.At 21 days, the incubated returned tubes showed no growth.This complaint cannot be confirmed for appearance based on the photos of hazy media and returned tubes of trace hazy media.The coa for this product, the broth appearance is light yellow to medium tan yellow, clear to trace hazy.This is consistent with the photos and returns received.There was no growth after 21 days incubation bd will continue to trend complaints for contamination.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ TRYPTICASE¿ SOY BROTH
Type of Device
CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL
Manufacturer (Section D)
BECTON DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jo doyka
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key18150723
MDR Text Key328304121
Report Number1119779-2023-01245
Device Sequence Number1
Product Code JSG
UDI-Device Identifier30382902217160
UDI-Public(01)30382902217160
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
SEE H.10
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date03/23/2024
Device Catalogue Number221716
Device Lot Number2272714
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/30/2023
Initial Date FDA Received11/16/2023
Supplement Dates Manufacturer Received03/19/2024
Supplement Dates FDA Received03/27/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/29/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-